Inactivation of the group A Streptococcus regulator srv results in chromosome wide reduction of transcript levels, and changes in extracellular levels of Sic and SpeB.

Group A Streptococcus is characterized by the ability to cause a diverse number of human infections including pharyngitis, necrotizing fasciitis, toxic shock syndrome, and acute rheumatic fever, yet the regulation of streptococcal genes involved in disease processes and survival in the host is not completely understood. Genome scale analysis has revealed a complex regulatory network including 13 two-component regulatory systems and more than 100 additional putative regulators, the majority of which remain uncharacterized. Among these is the streptococcal regulator of virulence, Srv, the first Group A Streptococcus member of the Crp/Fnr family of transcriptional regulators. Previous work demonstrated that the loss of srv resulted in a significant decrease in Group A Streptococcus virulence. To begin to define the gene products influenced by Srv, we combined microarray and two-dimensional gel electrophoresis analysis. Loss of srv results in a chromosome wide reduction of gene transcription and changes in the production of the extracellular virulence factors Sic (streptococcal inhibitor of complement) and SpeB (cysteine proteinase). Sic levels are reduced in the srv mutant, whereas the extracellular concentration and activity of SpeB is increased. These data link Srv to the increasingly complex GAS regulatory network.

[1]  Meng-Yao Liu,et al.  Genome sequence of a serotype M3 strain of group A Streptococcus: Phage-encoded toxins, the high-virulence phenotype, and clone emergence , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Musser,et al.  Multilocus analysis of extracellular putative virulence proteins made by group A Streptococcus: Population genetics, human serologic response, and gene transcription , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Todd M. Smith,et al.  Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  W. Goebel,et al.  Identification of a gene that positively regulates expression of listeriolysin, the major virulence factor of listeria monocytogenes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Musser,et al.  Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  W. Simpson,et al.  Expression of M type 12 protein by a group A streptococcus exhibits phaselike variation: evidence for coregulation of colony opacity determinants and M protein , 1987, Infection and immunity.

[7]  D. Bessen,et al.  Genetic correlates of throat and skin isolates of group A streptococci. , 1996, The Journal of infectious diseases.

[8]  J. Renau‐Piqueras,et al.  The Cell Wall-Associated Glyceraldehyde-3-Phosphate Dehydrogenase of Candida albicans Is Also a Fibronectin and Laminin Binding Protein , 1998, Infection and Immunity.

[9]  J. Musser,et al.  Identification and Immunogenicity of Group AStreptococcus Culture Supernatant Proteins , 2000, Infection and Immunity.

[10]  Yudong D. He,et al.  Functional Discovery via a Compendium of Expression Profiles , 2000, Cell.

[11]  B. Kreikemeyer,et al.  Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. , 2003, Trends in microbiology.

[12]  J. Musser,et al.  Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. , 2001, The Journal of infectious diseases.

[13]  J. Jensenius,et al.  EndoS and SpeB from Streptococcus pyogenes Inhibit Immunoglobulin-Mediated Opsonophagocytosis , 2002, Infection and Immunity.

[14]  M. Federle,et al.  A Response Regulator That Represses Transcription of Several Virulence Operons in the Group A Streptococcus , 1999, Journal of bacteriology.

[15]  J. Carapetis,et al.  Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. , 2000, The Journal of infectious diseases.

[16]  J. Musser,et al.  Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions. , 2001, The Journal of clinical investigation.

[17]  Michael Y. Galperin,et al.  The COG database: a tool for genome-scale analysis of protein functions and evolution , 2000, Nucleic Acids Res..

[18]  V. DiRita,et al.  A Two-Component Regulatory System, CsrR-CsrS, Represses Expression of Three Streptococcus pyogenesVirulence Factors, Hyaluronic Acid Capsule, Streptolysin S, and Pyrogenic Exotoxin B , 1999, Infection and Immunity.

[19]  M. Chaussee,et al.  The rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production. , 1999, Infection and immunity.

[20]  M. Wessels,et al.  Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus , 1998, Molecular microbiology.

[21]  J. Tagg,et al.  A simple plate assay for detection of group A streptococcus proteinase , 1985 .

[22]  J. Musser,et al.  Progress toward characterization of the group A Streptococcus metagenome: complete genome sequence of a macrolide-resistant serotype M6 strain. , 2004, The Journal of infectious diseases.

[23]  S. Jones,et al.  Streptococcus pyogenes type 12 M protein gene regulation by upstream sequences , 1987, Journal of bacteriology.

[24]  Morag R. Graham,et al.  Global differential gene expression in response to growth temperature alteration in group A Streptococcus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Schmidtchen,et al.  Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37 , 2002, Molecular microbiology.

[26]  J. Musser,et al.  Identification of Rgg-Regulated Exoproteins ofStreptococcus pyogenes , 2001, Infection and Immunity.

[27]  V. Fischetti,et al.  Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever , 1989, The Journal of experimental medicine.

[28]  J. Musser,et al.  Identification of srv, a PrfA-Like Regulator of Group A Streptococcus That Influences Virulence , 2004, Infection and Immunity.

[29]  V. DiRita,et al.  Contribution of CsrR-Regulated Virulence Factors to the Progress and Outcome of Murine Skin Infections by Streptococcus pyogenes , 2004, Infection and Immunity.

[30]  A. Bretscher,et al.  Insight into the molecular basis of pathogen abundance: Group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Caparon,et al.  Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Musser,et al.  Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Pichichero,et al.  Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. , 2000, The Journal of infectious diseases.

[34]  S. Jones,et al.  Small DNA deletions creating avirulence in Streptococcus pyogenes. , 1984, Science.

[35]  L. Björck,et al.  Protein SIC, a Novel Extracellular Protein of Streptococcus pyogenes Interfering with Complement Function (*) , 1996, The Journal of Biological Chemistry.

[36]  B. Modun,et al.  The Staphylococcal Transferrin-Binding Protein Is a Cell Wall Glyceraldehyde-3-Phosphate Dehydrogenase , 1999, Infection and Immunity.

[37]  B. Spratt,et al.  Multilocus Sequence Typing of Streptococcus pyogenes Representing Most Known emm Types and Distinctions among Subpopulation Genetic Structures , 2004, Journal of bacteriology.

[38]  J. Musser,et al.  Virulence control in group A Streptococcus by a two-component gene regulatory system: Global expression profiling and in vivo infection modeling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Musser,et al.  Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. , 1997, The Journal of clinical investigation.

[40]  Bruce A. Roe,et al.  Complete genome sequence of an M1 strain of Streptococcus pyogenes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  V. DiRita,et al.  Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. , 2001, The Journal of infectious diseases.

[42]  Masahira Hattori,et al.  Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution. , 2003, Genome research.

[43]  J. Musser,et al.  A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. , 1993, Microbial pathogenesis.

[44]  M. Chaussee,et al.  Rgg Regulates Growth Phase-Dependent Expression of Proteins Associated with Secondary Metabolism and Stress in Streptococcus pyogenes , 2004, Journal of bacteriology.

[45]  D. Bessen,et al.  Genetic linkage of exotoxin alleles and emm gene markers for tissue tropism in group A streptococci. , 1999, The Journal of infectious diseases.

[46]  J. Musser,et al.  Nonpolar Inactivation of the Hypervariable Streptococcal Inhibitor of Complement Gene (sic) in Serotype M1 Streptococcus pyogenes Significantly Decreases Mouse Mucosal Colonization , 2000, Infection and Immunity.

[47]  J. Musser,et al.  6 The revival of group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome , 1998 .